HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haichang Wang Selected Research

Inflammation (Inflammations)

2/2016Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation.
2/2015Activation of κ-opioid receptor by U50,488H improves vascular dysfunction in streptozotocin-induced diabetic rats.
1/2014TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury.
5/2008Insulin inhibits tumor necrosis factor-alpha induction in myocardial ischemia/reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haichang Wang Research Topics

Disease

19Infarction (Infarctions)
01/2022 - 02/2003
16Myocardial Infarction
01/2022 - 05/2008
16Reperfusion Injury
06/2015 - 07/2009
13Myocardial Ischemia (Ischemic Heart Diseases)
06/2015 - 05/2008
10Hypoxia (Hypoxemia)
01/2017 - 01/2011
10Ischemia
01/2017 - 05/2008
9Atherosclerosis
12/2020 - 02/2008
8Diabetic Cardiomyopathies
09/2023 - 01/2011
8Thrombosis (Thrombus)
04/2021 - 08/2010
8Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 01/2012
7Insulin Resistance
01/2016 - 03/2008
5Fibrosis (Cirrhosis)
10/2016 - 07/2012
4Coronary Artery Disease (Coronary Atherosclerosis)
04/2021 - 01/2014
4Inflammation (Inflammations)
02/2016 - 05/2008
3Type 2 Diabetes Mellitus (MODY)
01/2020 - 10/2015
3ST Elevation Myocardial Infarction
03/2019 - 08/2009
3Ventricular Remodeling
09/2017 - 12/2015
3Hypertension (High Blood Pressure)
01/2017 - 08/2010
3Atherosclerotic Plaque (Atheroma)
02/2016 - 01/2016
3Diabetes Mellitus
02/2015 - 02/2012
3Hyperglycemia
08/2014 - 01/2012
2Cardiomegaly (Heart Hypertrophy)
01/2018 - 02/2015
2Mitochondrial Diseases (Mitochondrial Disease)
01/2017 - 01/2014
2Pathologic Constriction (Stenosis)
03/2015 - 11/2010
2Death (Near-Death Experience)
01/2014 - 11/2012
2Wounds and Injuries (Trauma)
07/2012 - 08/2011
2Critical Illness (Critically Ill)
10/2009 - 05/2008
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2009 - 01/2009
1Heart Injuries
01/2022
1Cardiomyopathies (Cardiomyopathy)
01/2020
1Coronary Disease (Coronary Heart Disease)
11/2017
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2016
1Coronary Stenosis (Coronary Artery Stenosis)
09/2016
1Acute Lung Injury
01/2016
1Heart Failure
01/2016

Drug/Important Bio-Agent (IBA)

12Glucose (Dextrose)FDA LinkGeneric
01/2016 - 03/2008
10Insulin (Novolin)FDA Link
02/2016 - 03/2008
6Small Interfering RNA (siRNA)IBA
10/2016 - 10/2012
5PolymersIBA
04/2021 - 01/2014
4Mitochondrial Aldehyde DehydrogenaseIBA
09/2023 - 01/2012
4Sirolimus (Rapamycin)FDA Link
04/2021 - 01/2014
4Sirtuin 3IBA
01/2019 - 01/2016
4AdiponectinIBA
06/2015 - 08/2011
4ThioredoxinsIBA
10/2012 - 07/2009
3Streptozocin (Streptozotocin)FDA Link
01/2022 - 01/2012
3Phosphotransferases (Kinase)IBA
01/2020 - 03/2014
3MelatoninIBA
10/2018 - 01/2017
3Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2016
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2015 - 05/2008
2ChromiumIBA
10/2017 - 01/2017
2CobaltIBA
10/2017 - 01/2017
2Beclin-1IBA
11/2016 - 01/2016
2Complementary DNA (cDNA)IBA
10/2016 - 09/2015
2Blood Glucose (Blood Sugar)IBA
02/2016 - 06/2014
2LipidsIBA
02/2016 - 02/2016
2Phosphatidylinositols (Phosphatidylinositol)IBA
02/2016 - 08/2009
2LuteolinIBA
01/2016 - 01/2012
2Etanercept (Enbrel)FDA Link
06/2015 - 08/2011
2Peptides (Polypeptides)IBA
01/2015 - 12/2012
2CD40 Ligand (CD40L)IBA
01/2015 - 08/2010
24- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
08/2014 - 10/2012
2Peroxidase (Myeloperoxidase)IBA
07/2014 - 05/2008
2Receptor for Advanced Glycation End ProductsIBA
06/2014 - 10/2012
2Advanced Glycation End ProductsIBA
06/2014 - 10/2011
2omega-Chloroacetophenone (Mace)IBA
01/2014 - 11/2012
2Glycogen Synthase (Synthase I)IBA
01/2012 - 08/2009
2AdipokinesIBA
09/2011 - 08/2011
2Immunoglobulin M (IgM)IBA
02/2010 - 02/2008
2oxidized low density lipoproteinIBA
02/2010 - 02/2008
2Creatine Kinase (Creatine Phosphokinase)IBA
10/2009 - 05/2008
1ApoferritinsIBA
01/2022
1Complement Factor D (Factor D)IBA
01/2022
1IronIBA
01/2022
1Transferrin Receptors (Transferrin Receptor)IBA
01/2022
1Becaplermin (PDGF-BB)FDA Link
12/2020
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2020
1Palmitic Acid (Hexadecanoic Acid)IBA
01/2020
1Nicorandil (SG 75)IBA
03/2019
114-3-3 Proteins (14-3-3 Protein)IBA
01/2018
1Simvastatin (Zocor)FDA LinkGeneric
01/2018
1Atorvastatin (Lipitor)FDA Link
12/2017
1CollagenIBA
12/2017
1EverolimusFDA Link
11/2017
1polydatinIBA
01/2017
1Collagen Type I (Type I Collagen)IBA
10/2016
1Tissue Inhibitor of MetalloproteinasesIBA
10/2016
1Metalloproteases (Metalloproteinases)IBA
10/2016
1mesoglycanIBA
09/2016
1Vasodilator Agents (Vasodilators)IBA
09/2016
1Interleukin-6 (Interleukin 6)IBA
02/2016
1Toll-Like Receptors (Toll-Like Receptor)IBA
02/2016
1TunicamycinIBA
01/2016
1Sildenafil Citrate (Viagra)FDA Link
01/2016
1Adenosine Triphosphate (ATP)IBA
01/2016
1ParaquatIBA
01/2016

Therapy/Procedure

10Therapeutics
02/2021 - 05/2008
8Stents
04/2021 - 11/2012
4Percutaneous Coronary Intervention
03/2019 - 07/2008
3Ligation
01/2016 - 09/2010
3Transplantation
07/2013 - 12/2007